Bibliografía del artículo
Areosa SA, Sherriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev 20(3):CD003154, 2005.
Bauer RM, Tobias B, Valenstein E. Amnesic disorders. In Heilman KM. Valenstein E (Eds). Clinical Neuropsychology. 3rd ed. Oxford University Press, New York, p 523-602, 1993.
Birks J. Cholinesterase Inhibitors for Alzheimer's Disease. Cochrane Database Syst Rev 25;(1):CD005593, 2006.
Bottino CMC. O tratamento de longo-prazo está indicado para pacientes com doença de Alzheimer? Rev Psiq Clin 32(6);341-2: 2005.
Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 8000:1403, 1976.
Davis KL, Mohs RC. Cholinergic drugs in Alzheimer's disease. N Engl J Med 315:1286-7, 1986.
Drachman DA, Leavitt J. Human memory and the cholinergic system. Arch Neurol 30:113-21, 1974.
Engelhardt E, Brucki SMD, Cavalcanti JL et al. Treatment of Alzheimer’s disease: Recommendations and suggestions of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Arq Neuropsiquiatr 63:1104-12, 2005.
Mayor S. NICE recommends drugs for moderate Alzheimer's disease. Br Med J 332(7535):195, 2006.
Mesulam MM, Van Hoesen GW. Acetylcholinesterase-rich projections from the basal forebrain of the Rhesus monkey to neocortex. Brain Res 109:152-7, 1976.
Nitrini R. The cure of one of the most frequent types of dementia: a historical parallel. Alzheimer Dis Assoc Disord 19:156-8, 2005.
Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ, Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333-41, 2003.
Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315:1241-5, 1986.
Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291:317-24, 2004.
Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-6, 1981.
Winblad B, Poritis N. Memantine in severe dementia: Results of the 9M-Best Study (Benefit and Efficacy in Severely Demented Patients during Treatment with Memantine). Int J Geriatr Psychiatry 14:135-46, 1999.